Direct Hit
With direct public offerings, entrepreneurs can take financing into their own hands.
Michael quinn's dilemma was a common one, but his solution was not.
After 10 years in business, Quinn wanted to go national. But his Hahnemann Laboratories Inc., a San Rafael, California, company that manufactures homeopathic medicines, needed to become a Food and Drug Administration-licensed pharmaceutical manufacturer if it was going to market its product across state lines. Where would Quinn get the capital to outfit a new facility?
Continue reading this article - and everything on Entrepreneur!
Become a member to get unlimited access and support the voices you want to hear more from. Get full access to Entrepreneur for just $5.
Get 3 months free with code zendesk
Presented by Zendesk
Entrepreneur Editors' Picks
-
Zooey Deschanel Embraces the Word 'Quirky' and Thinks Businesses Should Too
-
A Simple (But Not Easy) Guide to Achieving Almost Any Dream
-
Making Time to Be 'Useless' Is a Vital Part of Creating Anything Valuable
-
A Billionaire Who Operates More Than 2,400 Franchises Knows These Types of Franchisees Make the Most Money
-
How Relentless Optimism Fuels Success for Hilary Schneider, CEO of Shutterfly
-
The Paradox of Celebrity Tequila
-
Social Media Was Draining Me, So I Gave It Up. My Business Has Never Been Stronger.
